{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T02:12:01Z","timestamp":1721095921511},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12032-019-1284-y","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:02:47Z","timestamp":1559728967000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mortality rates and prognostic factors in patients with malignant salivary tumors"],"prefix":"10.1007","volume":"36","author":[{"given":"Yair","family":"Israel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Rachmiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Gourevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"1284_CR1","first-page":"143","volume-title":"Controversies in the management of salivary gland disease","author":"RH Spiro","year":"2001","unstructured":"Spiro RH. Factors affecting survival in salivary gland cancers. In: McGurk M, Renehan A, editors. Controversies in the management of salivary gland disease, Oxford: Oxford University Press; 2001. pp. 143\u201350."},{"issue":"8","key":"1284_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bjoms.2009.03.017","volume":"47","author":"PM Speight","year":"2009","unstructured":"Speight PM, Barrett AW. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 2009;47(8):587\u201393.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1284_CR3","first-page":"155","volume-title":"Controversies in the management of salivary gland disease","author":"M McGurk","year":"2001","unstructured":"McGurk M. Management of salivary gland cancer: clinically or pathologically based? Overview. In: McGurk M, Renehan A, editors. Controversies in the management of salivary gland disease, Oxford: Oxford University Press; 2001. pp. 155\u201361."},{"key":"1284_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/1097-0142(20000915)89:6<1195::AID-CNCR2>3.0.CO;2-J","volume":"89","author":"VL Vander Poorten","year":"2000","unstructured":"Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Keus RB, Hart AA. Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer. 2000;89:1195\u2013204.","journal-title":"Cancer"},{"key":"1284_CR5","first-page":"163","volume-title":"Controversies in the management of salivary gland disease","author":"N Slevin","year":"2001","unstructured":"Slevin N, Frankenthaler R. The role of radiotherapy in the management of salivary gland cancer. In: McGurk M, Renehan A, editors. Controversies in the management of salivary gland disease, Oxford: Oxford University Press; 2001. pp. 163\u201372."},{"issue":"7","key":"1284_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","volume":"47","author":"K Bj\u00f8rndal","year":"2011","unstructured":"Bj\u00f8rndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990\u20132005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2011;47(7):677\u201382. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2011.04.020\n                    \n                  .","journal-title":"Oral Oncol."},{"issue":"9","key":"1284_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ejso.2008.10.009","volume":"35","author":"JP Jeannon","year":"2009","unstructured":"Jeannon JP, Calman F, Gleeson M, et al. Management of advanced parotid cancer A systematic review. Eur J Surg Oncol. 2009;35(9):908\u201315. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2008.10.009\n                    \n                  .","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1284_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.joms.2013.05.024","volume":"72","author":"CP Nobis","year":"2014","unstructured":"Nobis CP, Rohleder NH, Wolff KD, Wagenpfeil S, Scherer EQ, Kesting MR. Head and neck salivary gland carcinomas--elective neck dissection, yes or no? J Oral Maxillofac Surg. 2014;72(1):205-10. \n                    https:\/\/doi.org\/10.1016\/j.joms.2013.05.024\n                    \n                  .","journal-title":"J Oral Maxillofac Surg"},{"key":"1284_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.joms.2014.12.036","volume":"73","author":"T Kope\u0107","year":"2015","unstructured":"Kope\u0107 T, Mikaszewski B, Jackowska J, Wa\u015bniewska-Okupniak E, Szyfter W, et al. Treatment of parotid malignancies\u201410\u00a0years of experience. J Oral Maxillofac Surg. 2015;73:1397\u2013402.","journal-title":"J Oral Maxillofac Surg"},{"key":"1284_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00405-011-1716-6","volume":"269","author":"D Stodulski","year":"2012","unstructured":"Stodulski D, Mikaszewski B, Stankiewicz C. Are all prognostic factors in parotid gland carcinoma well recognized? Eur Arch Otorhinolaryngol. 2012;269:1019\u201325. \n                    https:\/\/doi.org\/10.1007\/s00405-011-1716-6\n                    \n                  .","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1284_CR11","volume-title":"World Health Organization classification of tumors: pathology and genetics of head and neck tumors","year":"2005","unstructured":"Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumors: pathology and genetics of head and neck tumors, Lyon: IARC Press; 2005."},{"key":"1284_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hed.21433","volume":"33","author":"RR Walvekar","year":"2011","unstructured":"Walvekar RR, Andrade Filho PA, Seethala RR, et al. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. Head Neck. 2011;33:225\u201331.","journal-title":"Head Neck"},{"issue":"S2","key":"1284_CR13","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1017\/S0022215116000566","volume":"130","author":"S Sood","year":"2016","unstructured":"Sood S, McGurk M, Vaz F. Management of salivary gland tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S142\u20139.","journal-title":"J Laryngol Otol"},{"key":"1284_CR14","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1245\/s10434-016-5353-6","volume":"23","author":"JK Cho","year":"2016","unstructured":"Cho JK, Lim BW, Kim EH, et al. Low-grade salivary gland cancers: Treatment outcomes, extent of surgery and indications for postoperative adjuvant radiation therapy. Ann Surg Oncol. 2016;23:4368\u201375 \n                    https:\/\/doi.org\/10.1245\/s10434-016-5353-6\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1284_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.coms.2018.06.007","volume":"30","author":"JE Lubek","year":"2018","unstructured":"Lubek JE. Head and neck cancer research and support foundations. Oral Maxillofac Surg Clin North Am. 2018;30(4):459-69.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"12","key":"1284_CR16","doi-asserted-by":"publisher","first-page":"e115936","DOI":"10.1371\/journal.pone.0115936","volume":"9","author":"M Kinouchi","year":"2014","unstructured":"Kinouchi M, Uchida D, Kuribayashi N, Tamatani T, Nagai H, Miyamoto Y. Involvement of miR-518c-5p to growth and metastasis in oral cancer. PLoS One. 2014;9(12):e115936. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0115936\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1284_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/1471-2407-14-442","volume":"14","author":"HC Wang","year":"2014","unstructured":"Wang HC, Chiang WF, Huang HH, Shen YY, Chiang HC. Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis. BMC Cancer. 2014;14:442. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-442\n                    \n                  .","journal-title":"BMC Cancer"},{"issue":"3","key":"1284_CR18","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1111\/odi.12133","volume":"20","author":"YZ Kuo","year":"2014","unstructured":"Kuo YZ, Tai YH, Lo HI, et al. MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral Dis. 2014;20(3):e65-75. \n                    https:\/\/doi.org\/10.1111\/odi.12133\n                    \n                  .","journal-title":"Oral Dis"},{"issue":"2","key":"1284_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3835(02)00265-3","volume":"186","author":"RM Nagler","year":"2002","unstructured":"Nagler RM, Kerner H, Laufer D, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett. 2002;186(2):137-50.","journal-title":"Cancer Lett"},{"issue":"8","key":"1284_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hed.23716","volume":"37","author":"R Noorlag","year":"2015","unstructured":"Noorlag R, van der Groep P, Leusink FK, et al. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2. Head Neck. 2015;37(8):1130-6.","journal-title":"Head Neck"},{"key":"1284_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1017\/S0022215100133006","volume":"110","author":"P Pisani","year":"1996","unstructured":"Pisani P, Ramponi A, Pia F. The deep parotid lymph nodes: an anatomical and oncological study. J Laryngol Otol. 1996;110:148\u201350.","journal-title":"J Laryngol Otol"},{"key":"1284_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0007-1226(85)90078-5","volume":"38","author":"ME McKean","year":"1985","unstructured":"McKean ME, Lee K, McGregor IA. The distribution of lymph nodes in and around the parotid gland: an anatomical study. Br J Plast Surg. 1985;38:1\u20135.","journal-title":"Br J Plast Surg"},{"key":"1284_CR23","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1007\/s00405-017-4767-5","volume":"274","author":"KD Olsen","year":"2017","unstructured":"Olsen KD, Quer M, de Bree R, Vander Poorten V, Rinaldo A, Ferlito A. Deep lobe parotidectomy\u2014why, when, and how? Eur Arch Otorhinolaryngol. 2017;274:4073\u20138. \n                    https:\/\/doi.org\/10.1007\/s00405-017-4767-5\n                    \n                  .","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1284_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaoto.2014.352","volume":"140","author":"JJ Thom","year":"2014","unstructured":"Thom JJ, Moore EJ, Price DL, Kasperbauer JL, Starkman SJ, Olsen KD. The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg. 2014;140:548\u201354.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"1284_CR25","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/hed.24810","volume":"39","author":"AP Wertz","year":"2017","unstructured":"Wertz AP, Durham AB, Malloy KM, Johnson TM, Bradford CR, McLean SA. Total versus superficial parotidectomy for stage III melanoma. Head Neck. 2017;39:1665\u201370.","journal-title":"Head Neck"},{"key":"1284_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9","volume":"69","author":"JG Armstrong","year":"1992","unstructured":"Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69:615\u20139.","journal-title":"Cancer"},{"key":"1284_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00405-013-2616-8","volume":"271","author":"KD Olsen","year":"2014","unstructured":"Olsen KD, Moore EJ. Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer. Eur Arch Otorhinolaryngol. 2014;271:1181\u20135.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"1284_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4103\/0019-509X.123629","volume":"50","author":"N Dwivedi","year":"2013","unstructured":"Dwivedi N, Agarwal A, Raj V, Chandra S. Histogenesis of salivary gland neoplasms. Indian J Cancer. 2013;50(4):361-6.","journal-title":"Indian J Cancer"},{"issue":"4","key":"1284_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12105-009-0139-9","volume":"3","author":"FA de Oliveira","year":"2009","unstructured":"de Oliveira FA, Duarte EC, Taveira CT, et al. Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol. 2009;3(4):271-5.","journal-title":"Head Neck Pathol"},{"key":"1284_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.oraloncology.2007.05.010","volume":"44","author":"AV Jones","year":"2008","unstructured":"Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44:407\u201317.","journal-title":"Oral Oncol"},{"issue":"2","key":"1284_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74(2):134-48. .","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1284_CR32","first-page":"1101","volume":"118","author":"LB Ungureanu","year":"2014","unstructured":"Ungureanu LB, Ciobanu D, Danciu M, et al. Epidemiology and pathology of parotid tumors five-year retrospective study. Rev Med Chir Soc Med Nat Iasi. 2014;118(4):1101-7.","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"1B","key":"1284_CR33","first-page":"701","volume":"17","author":"RM Nagler","year":"1997","unstructured":"Nagler RM, Laufer D. Tumors of the major and minor salivary glands: review of 25\u00a0years of experience. Anticancer Res. 1997;17(1B):701-7.","journal-title":"Anticancer Res"},{"key":"1284_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oraloncology.2016.12.016","volume":"66","author":"S Alfieri","year":"2017","unstructured":"Alfieri S, Granata R, Bergamini C, et al. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? Oral Oncol. 2017;66:58-63.","journal-title":"Oral Oncol"},{"key":"1284_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.oraloncology.2017.09.008","volume":"74","author":"NC Schmitt","year":"2017","unstructured":"Schmitt NC, Kang H, Sharma A. Salivary duct\u00a0carcinoma: An aggressive\u00a0salivary\u00a0gland malignancy with opportunities for targeted therapy. Oral Oncol. 2017;74:40-8.","journal-title":"Oral Oncol"},{"issue":"11","key":"1284_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.oraloncology.2009.07.001","volume":"45","author":"AW Barrett","year":"2009","unstructured":"Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator? Oral Oncol. 2009;45(11):936-40.","journal-title":"Oral Oncol"},{"issue":"6","key":"1284_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/0194599817751888","volume":"158","author":"P Huyett","year":"2018","unstructured":"Huyett P, Duvvuri U, Ferris RL, Johnson JT, Schaitkin BM, Kim S. Perineural invasion in parotid gland malignancies. Otolaryngol Head Neck Surg. 2018;158(6):1035-41. \n                    https:\/\/doi.org\/10.1177\/0194599817751888\n                    \n                  .","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:24:35Z","timestamp":1591226675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1284-y","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"65"}}